retatrutide phase 3 results october 2025 Updates: Significant Weight Loss and Improved Complications | Ahmad Bahareth, MD posted on the topic Retatrutide Phase 3: TRIUMPH Program

Several evidence-based strategies complement the medication effects and can improve both weight loss outcomes and overall postpartum recovery

For now we dont have that information with GLP-1 products, but we are collecting the information so we will see. But the growing use of GLP-1 drugs is also thought to be fuelling other abuses

This strategic design allows researchers to fully engage the GIP pathway for enhanced metabolic effects while minimizing the dose-limiting gastrointestinal tolerability issues common with high-dose GLP-1 agonism, making it uniquely valuable for studying synergistic incretin mechanisms

Suzuki, S., Kawai, K., Ohashi, S., Mukai, H